1. Aziyo Biologics, a regenerative medicine company, voluntarily recalled a lot of its FiberCel product after several patients who received it tested positive for tuberculosis, according to the FDA.
2. DiFusion Technologies added Todd Potokar to its board of directors and named Rich Grant as chair of the board.
3. The FDA has provided clearance for Medtronic’s Vanta, a recharge free implantable neurostimulator.
4. SeaSpine’s WaveForm L 3D-printed interbody system was released in a limited commercial launch.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.